Webinar Series: Genetic Expression Profile Testing

Genetic Expression Profile (GEP) testing has been a controversial topic in dermatology over the last few years. The use of GEP has increased despite a lack of understanding of risks and benefits. This webinar will review the most up-to-date recommendations and demonstrate a practical approach on how to incorporate in daily practice. This webinar is the final session in a three-part series on the role of genetics in dermatology. 

Presented by: Orit Markowitz, MD

Learning objectives:

At the conclusion of this webinar, participants will recognize:

• What is Genetic Expression Profile (GEP) testing.
• What are the different types if GEP testing and their uses.
• What are the current controversies of GEP testing.
• A practical approach on how to incorporate GEP testing into daily practice.

 CME Credits
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 8/16/2023 to 8/16/2024. AAPA reference number: CME-209832.  
 
Speaker Bio
 Dr. Orit Markowitz is a leading dermatologist, skin cancer specialist, and CEO and Founder of Markowitz Medical. She has been called a dermatologic pioneer for her groundbreaking work developing minimally-invasive diagnostic and treatment protocols for skin cancer. Her motto: Cutting Edge Without the Cutting™

Over the past decade, Dr. Markowitz has served as Director of Pigmented Lesions and Skin Cancer at both Mount Sinai Department of Dermatology and Brooklyn Veterans Hospital of Downstate University Medical Center, as well as Associate Professor of Dermatology at Mount Sinai and SUNY Downstate University Medical Center.

Dr. Markowitz is considered a leading educator in noninvasive skin cancer therapies. She has directed imaging courses for the American Academy of Dermatology (AAD), she trains all residents in the greater New York area on dermoscopy, and she wrote A Practical Guide to Dermoscopy, the leading handbook on the topic. Dr. Markowitz has also lectured at numerous AAD conferences, is President of the International Optical Coherence Tomography Society, Chair of the AAD’s Quality Assurance and Education Committee Cutaneous Imaging Group, and she was the chair of the Second World Congress of Confocal Microscopy Conference.

Considered one of the world’s leading researchers in nonsurgical skin cancer treatment, Dr. Markowitz opened Markowitz Medical, in part, to act as her primary research lab. Dr. Markowitz has acted as principal investigator in multiple U.S. clinical trials studying the use of noninvasive imaging in skin cancer, precancer, psoriasis and eczema, and her most recent funded imaging research includes early diagnosis and optimal management of skin cancer and prognostic indicators of medications on disease, such as field cancerization, psoriasis, atopic dermatitis, nail fungus and allergy patch testing. Dr. Markowitz was the recipient of 2018 Melanoma Research Humanitarian Award for her groundbreaking work in early melanoma diagnosis and significant contributions to the treatment and care of melanoma patients.